(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

FedEx Q4 Earnings Preview: Analysts' Targets for Atlanticus, GigaCloud, Bio-Rad Labs, EnerSys

June 17th, 2023

FedEx Corp. (NYSE: FDX), a global logistics and delivery services company, is set to release its fourth-quarter fiscal 2023 financial results on Tuesday, June 20, 2023, after the market closes.  Analysts are anticipating a consensus earnings . Read more

Boeing Lands $28.8M+ Contracts; Upbeat PTs for Bionomics, DraftKings, XPO, and Equinix

June 17th, 2023

The Boeing Company (NYSE: BA) has been awarded two contracts totaling $28,831,462. The first contract, valued at $16,848,306, is a cost-plus-fixed-fee contract for design agent and technical engineering services. It is for the AN/USQ-82(V) family . Read more

Cano Health Surges On Restructured Leadership; Lennar On PT Boosts

June 17th, 2023

Shares of Cano Health, Inc. (NYSE: CANO) surged in after-hours trading Friday as the company announced a change in its executive leadership to advance its strategy for stockholder value creation.  Dr. Marlow Hernandez has agreed to step down . Read more

President Biden's Message to Congress: Pass the George Floyd Justice in Policing Act

June 16th, 2023

The independent findings released by the Department of Justice regarding the unconstitutional practices of the Minneapolis Police Department have brought forth a pressing issue that demands immediate attention. President Biden, upon receiving the bri. Read more

Nikola Reveals Strategic Moves, MorphoSys Surges on Positive PT Revisions

June 16th, 2023

Nikola Corporation (Nasdaq: NKLA) has provided a progress update on its business optimization efforts, which aim to streamline operations and reduce cash spend. As part of these initiatives, the company conducted a thorough review of its organization. Read more

Nikola Strikes Back; Analysts Bullish on Jabil

June 16th, 2023

In a regulatory filing with the SEC, Nikola Corporation (Nasdaq: NKLA) has responded to a recent social media post by its former CEO, Trevor Milton, stating that it misstates the facts. According to the company, since Milton's departure in September . Read more

UK's CMA OKs Amazon's iRobot Purchase; Morgan Stanley PT Boosts NVIDIA, AMD, Adobe, Intel, Marvell

June 16th, 2023

The Competition and Markets Authority (CMA) in the UK has cleared Amazon.com, Inc.'s (Nasdaq: AMZN) $1.7 billion purchase of iRobot Corporation (Nasdaq: IRBT), the maker of Roomba robot vacuum cleaners.  The CMA examined potential concerns re. Read more

Coherus BioSciences Is To Takeover Surface Oncology

June 16th, 2023

Coherus BioSciences, Inc. (Nasdaq: CHRS) and Surface Oncology, Inc. (Nasdaq: SURF) have entered into a definitive merger agreement where Coherus will acquire Surface Oncology in a stock for stock transaction valued at up to $65 million.  This. Read more

Evelo Biosciences Granted U.S. Patent; Needham: Opportunity On DoubleVerify, and Clearfield

June 16th, 2023

Evelo Biosciences, Inc. (Nasdaq: EVLO), a biotechnology company, has been awarded U.S. Patent No. US 11,672,834 B2 by The United States Patent and Trademark Office (USPTO). The patent, titled "Probiotic and prebiotic compositions, and methods of u. Read more

Momentum Building: Reata Pharma, Virgin Galactic, Squarespace Make Key Announcements

June 16th, 2023

Reata Pharmaceuticals, Inc. (Nasdaq: RETA) made a significant announcement as the U.S. Food and Drug Administration (FDA) accepted the filing of the Prior Approval Supplement (PAS) for SKYCLARYS (omaveloxolone).  This acceptance signifies tha. Read more